| Jun 26 |
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
|
| Jun 26 |
Pharma M&A: The top high value deals in 2023
|
| Jun 25 |
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
|
| Jun 25 |
ASCO24: Novartis’ Scemblix outperforms standard of care in CML
|
| Jun 24 |
Here's Why Novartis (NVS) is a Strong Value Stock
|
| Jun 21 |
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
|
| Jun 20 |
Here's Why Novartis (NVS) is a Strong Momentum Stock
|
| Jun 20 |
Novartis intends to implement merger squeeze-out of MorphoSys minority shareholders
|
| Jun 19 |
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
|
| Jun 17 |
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
|
